Select Medical Holdings Co. (NYSE:SEM) Shares Sold by Y Intercept Hong Kong Ltd

Y Intercept Hong Kong Ltd reduced its position in shares of Select Medical Holdings Co. (NYSE:SEM) by 58.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 9,425 shares of the health services provider’s stock after selling 13,143 shares during the period. Y Intercept Hong Kong Ltd’s holdings in Select Medical were worth $329,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the business. Quarry LP acquired a new position in shares of Select Medical in the 3rd quarter worth approximately $30,000. Transcendent Capital Group LLC bought a new stake in Select Medical during the second quarter worth approximately $35,000. Canada Pension Plan Investment Board acquired a new position in Select Medical in the second quarter worth approximately $39,000. DekaBank Deutsche Girozentrale bought a new position in shares of Select Medical in the second quarter valued at $60,000. Finally, GAMMA Investing LLC lifted its position in shares of Select Medical by 16.6% during the 3rd quarter. GAMMA Investing LLC now owns 2,313 shares of the health services provider’s stock valued at $81,000 after acquiring an additional 330 shares during the last quarter. 89.48% of the stock is currently owned by institutional investors.

Select Medical Trading Down 2.6 %

Shares of NYSE SEM opened at $19.12 on Wednesday. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.37. Select Medical Holdings Co. has a one year low of $19.05 and a one year high of $40.98. The business has a 50-day moving average price of $30.97 and a two-hundred day moving average price of $33.67. The firm has a market capitalization of $2.48 billion, a PE ratio of 8.93, a PEG ratio of 0.39 and a beta of 1.43.

Select Medical (NYSE:SEM) last announced its quarterly earnings data on Thursday, October 31st. The health services provider reported $0.43 EPS for the quarter, beating analysts’ consensus estimates of $0.36 by $0.07. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The firm had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.74 billion. During the same period in the previous year, the firm posted $0.46 earnings per share. The firm’s revenue was up 5.7% on a year-over-year basis. As a group, analysts predict that Select Medical Holdings Co. will post 1.97 earnings per share for the current fiscal year.

Select Medical Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, November 26th. Shareholders of record on Wednesday, November 13th were paid a $0.125 dividend. The ex-dividend date was Wednesday, November 13th. This represents a $0.50 dividend on an annualized basis and a yield of 2.62%. Select Medical’s dividend payout ratio (DPR) is currently 23.36%.

Insiders Place Their Bets

In other news, VP Robert G. Breighner, Jr. sold 4,989 shares of the stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total transaction of $99,530.55. Following the transaction, the vice president now owns 30,356 shares in the company, valued at $605,602.20. This represents a 14.12 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Marilyn B. Tavenner sold 32,000 shares of Select Medical stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $21.09, for a total transaction of $674,880.00. Following the completion of the sale, the director now directly owns 22,000 shares of the company’s stock, valued at approximately $463,980. The trade was a 59.26 % decrease in their position. The disclosure for this sale can be found here. Insiders own 19.14% of the company’s stock.

Wall Street Analysts Forecast Growth

SEM has been the topic of a number of recent analyst reports. StockNews.com raised Select Medical from a “hold” rating to a “buy” rating in a research report on Tuesday, December 3rd. Royal Bank of Canada upped their price objective on shares of Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a research note on Monday, November 4th. Bank of America assumed coverage on shares of Select Medical in a research report on Tuesday, August 20th. They issued a “buy” rating and a $42.00 target price on the stock. Finally, Benchmark downgraded shares of Select Medical from a “buy” rating to a “hold” rating in a research report on Monday, November 25th.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.